HSBC HOLDINGS PLC

Position in AKBA — Akebia Therapeutics, Inc.

CIK 873630 LONDON, X0

Position in AKBA

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$205,847

+$102,803 QoQ

Shares Held

148,092

+423.1% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

HSBC HOLDINGS PLC holds $402,322,473 across 27 Drug Manufacturers - Specialty & Generic names. AKBA ranks #18 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	2,063,170	$243,887,321
2	UTHR	UNITED THERAPEUTICS Corp	119,235	$70,703,969
3	TEVA	Teva Pharmaceutical Industries Ltd	961,140	$28,949,535
4	NBIX	Neurocrine Biosciences Inc	184,222	$24,269,403
5	VTRS	Viatris Inc	1,715,900	$23,181,805
6	HIMS	Hims & Hers Health, Inc.	84,159	$1,747,140
7	ALKS	Alkermes plc.	48,337	$1,709,196
8	RDY	Dr Reddys Laboratories Ltd	78,293	$1,084,357

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$205,847	148,092	+423.1%	Shares	Defined	2026-04-30
2025-06-30	$103,044	28,309	-60.0%	Shares	Defined	2025-08-13
2025-03-31	$136,001	70,834	+1.2%	Shares	Defined	2025-05-14
2024-12-31	$133,009	70,005	+27.3%	Shares	Defined	2025-02-14
2024-09-30	$72,564	54,973	-20.5%	Shares	Defined	2024-11-14
2022-03-31	$49,618	69,107	-26.6%	Shares	Defined	2022-05-16
2021-12-31	$212,744	94,135	+141.0%	Shares	Defined	2022-02-11
2021-09-30	$112,498	39,062	0.0%	Shares	Other	2021-11-12
2021-06-30	$148,044	39,062	0.0%	Shares	Other	2021-08-13
2021-03-31	$132,224	39,062	-25.1%	Shares	Other	2021-05-14
2020-12-31	$145,946	52,124	-17.9%	Shares	Other	2021-02-25
2020-09-30	$159,289	63,462	+127.2%	Shares	Other	2020-11-12
2020-06-30	$379,289	27,930	-7.3%	Shares	Defined	2020-08-14
2020-03-31	$228,302	30,119	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.